Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats

Author： Tyagi Sandeep Sharma Saurabh Budhiraja Ramji Dass

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.90, Iss.7, 2012-07, pp. : 881-885

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Apelin-13 deteriorates hypertension in rats after damage of the vascular endothelium by ADMA

By Zhang Dong-Liang Yin Dao-Xin Zhang Qi-Dong Liu Wen-Hu

Canadian Journal of Physiology and Pharmacology, Vol. 91, Iss. 9, 2013-01 ,pp. : 708-714

NRC Research Press

Access to resources Recommend Favorite

Inhibition of phosphatidylinositol 3-kinase

By Zahradka P.

Expert Opinion on Therapeutic Targets, Vol. 2, Iss. 1, 1998-07 ,pp. : 97-99

Informa Healthcare

Access to resources Recommend Favorite

The phosphatidylinositol 3-kinase inhibitor wortmannin markedly reduces chemotactic peptide-induced locomotion and increases in cytoskeletal actin in human neutrophils

By Niggli V. Keller H.

European Journal of Pharmacology, Vol. 335, Iss. 1, 1997-09 ,pp. : 43-52

Elsevier

Access to resources Recommend Favorite

Halenaquinone, a novel phosphatidylinositol 3-kinase inhibitor from a marine sponge, induces apoptosis in PC12 cells

By Fujiwara H. Matsunaga K. Saito M. Hagiya S. Furukawa

European Journal of Pharmacology, Vol. 413, Iss. 1, 2001-02 ,pp. : 37-45

Elsevier

Access to resources Recommend Favorite

CAL-101: a phosphatidylinositol-3-kinase p110-delta inhibitor for the treatment of lymphoid malignancies

By Castillo Jorge J Furman Michael Winer Eric S

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 1, 2012-01 ,pp. : 15-22

Informa Healthcare

Access to resources Recommend Favorite